Embarazo, parto, infancia, adultez | 26 OCT 20

Síndrome de Down

Actualización sobre epidemiología, diagnóstico, manifestaciones clínicas y abordaje del Síndrome de Down
Autor/a: Marilyn J. Bull N Engl J Med 2020;382:2344-52
INDICE:  1. Texto principal | 2. Texto principal
Texto principal

1. de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A 2015; 167A: 756-67.

2. Down JL. Observations on an ethnic classification of idiots: 1866. Ment Retard 1995; 33: 54-6.

3. Lejeune J, Gauthier M, Turpin R. Human chromosomes in tissue cultures. C R Hebd Seances Acad Sci 1959; 248: 602-3. (In French.)

4. Gautier M. Fiftieth anniversary of the trisomy 21: return on a discovery. Med Sci (Paris) 2009; 25: 311-5. (In French.)

5. Allen G, Benda CE, Böök JA, et al. Mongolism. Am J Hum Genet 1961; 13: 426.

6. Coppedè F. The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects. Front Genet 2015; 6: 223.

7. Hook EB. Epidemiology of Down syndrome. In: Pueschel SM, Rynders JE, eds. Down syndrome: advances in biomedicine and the behavioral sciences. Cambridge, MA: Ware Press, 1982: 11-88.

8. Papavassiliou P, Charalsawadi C, Rafferty K, Jackson-Cook C. Mosaicism for trisomy 21: a review. Am J Med Genet A 2015; 167A: 26-39.

9. Pelleri MC, Cicchini E, Locatelli C, et al. Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype. Hum Mol Genet 2016; 25: 2525-38.

10. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 249-66.

11. Committee on Practice Bulletins — Obstetrics, Committee on Genetics, and the Society for Maternal-Fetal Medicine. Practice bulletin no. 163: screening for fetal aneuploidy. Obstet Gynecol 2016; 127(5): e123-e137.

12. Skotko BG, Capone GT, Kishnani PS, Down Syndrome Diagnosis Study Group. Postnatal diagnosis of Down syndrome: synthesis of the evidence on how best to deliver the news. Pediatrics 2009; 124(4): e751-e758.

13. Meredith SH. Understanding a Down syndrome diagnosis. Lexington: University of Kentucky, 2019.

14. Guseh SH, Little SE, Bennett K, Silva V, Wilkins-Haug LE. Antepartum management and obstetric outcomes among pregnancies with Down syndrome from diagnosis to delivery. Prenat Diagn 2017; 37: 640-6.

15. Bull MJ, Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2011; 128: 393-406.

16. Freeman SB, Taft LF, Dooley KJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80: 213-7.

17. Weijerman ME, van Furth AM, van der Mooren MD, et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 2010; 169: 1195-9.

18. O’Leary L, Hughes-McCormack L, Dunn K, Cooper SA. Early death and causes of death of people with Down syndrome: a systematic review. J Appl Res Intellect Disabil 2018; 31: 687-708.

19. Kreicher KL, Weir FW, Nguyen SA, Meyer TA. Characteristics and progression of hearing loss in children with Down syndrome. J Pediatr 2018; 193: 27-33.e2.

20. Park AH, Wilson MA, Stevens PT, Harward R, Hohler N. Identification of hearing loss in pediatric patients with Down syndrome. Otolaryngol Head Neck Surg 2012; 146: 135-40.

21. Taub JW, Berman JN, Hitzler JK, et al. Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial. Blood 2017; 129: 3304-13.

22. Hasle H, Friedman JM, Olsen JH, Rasmussen SA. Low risk of solid tumors in persons with Down syndrome. Genet Med 2016; 18: 1151-7.

23. Dixon NE, Crissman BG, Smith PB, Zimmerman SA, Worley G, Kishnani PS. Prevalence of iron deficiency in children with Down syndrome. J Pediatr 2010; 157(6): 967-971.e1.

24. Hoffmire CA, Magyar CI, Connolly HV, Fernandez ID, van Wijngaarden E. High prevalence of sleep disorders and associated comorbidities in a community sample of children with Down syndrome. J Clin Sleep Med 2014; 10: 411-9.

25. Pierce MJ, LaFranchi SH, Pinter JD. Characterization of thyroid abnormalities in a large cohort of children with Down syndrome. Horm Res Paediatr 2017; 87: 170-8.

26. Jackson A, Maybee J, Moran MK, Wolter-Warmerdam K, Hickey F. Clinical characteristics of dysphagia in children with Down syndrome. Dysphagia 2016; 31: 663-71.

27. Stafstrom CE, Patxot OF, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics and outcome. Dev Med Child Neurol 1991; 33: 191-200.

28. Worley G, Crissman BG, Cadogan E, Milleson C, Adkins DW, Kishnani PS. Down syndrome disintegrative disorder: new-onset autistic regression, dementia, and insomnia in older children and adolescents with Down syndrome. J Child Neurol 2015; 30: 1147-52.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024